

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.77117114 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.64507430 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.59725029 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.39171426 |
| 5 | detection of bacterium (GO:0016045) | 3.94982939 |
| 6 | response to muramyl dipeptide (GO:0032495) | 3.92362473 |
| 7 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.91758611 |
| 8 | detection of other organism (GO:0098543) | 3.87074115 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 3.75228730 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 3.75228730 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.75228730 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.75228730 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.75228730 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 3.75228730 |
| 15 | regulation of cholesterol homeostasis (GO:2000188) | 3.71819316 |
| 16 | leukocyte aggregation (GO:0070486) | 3.67871761 |
| 17 | positive regulation of histone deacetylation (GO:0031065) | 3.67351369 |
| 18 | negative thymic T cell selection (GO:0045060) | 3.66913019 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.62271996 |
| 20 | germinal center formation (GO:0002467) | 3.55479080 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.46419280 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 3.44700607 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 3.41258905 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.39988387 |
| 25 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.39188532 |
| 26 | locomotory exploration behavior (GO:0035641) | 3.35418979 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.31346960 |
| 28 | B cell receptor signaling pathway (GO:0050853) | 3.30899671 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.27270229 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 3.27270229 |
| 31 | response to peptidoglycan (GO:0032494) | 3.26957551 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.20697869 |
| 33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.20697869 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.19105585 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.15981606 |
| 36 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11902936 |
| 37 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.11035340 |
| 38 | sodium ion export (GO:0071436) | 3.10441104 |
| 39 | L-phenylalanine metabolic process (GO:0006558) | 3.10258977 |
| 40 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.10258977 |
| 41 | regulation of histone H3-K27 methylation (GO:0061085) | 3.01992746 |
| 42 | neutrophil activation involved in immune response (GO:0002283) | 3.00694126 |
| 43 | cellular extravasation (GO:0045123) | 3.00361681 |
| 44 | regulation of ARF GTPase activity (GO:0032312) | 2.98579545 |
| 45 | regulation of ARF protein signal transduction (GO:0032012) | 2.98519743 |
| 46 | histone H3-K36 demethylation (GO:0070544) | 2.97604519 |
| 47 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.97244874 |
| 48 | response to interleukin-15 (GO:0070672) | 2.96361294 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.95632384 |
| 50 | positive regulation of Rap GTPase activity (GO:0032854) | 2.93505117 |
| 51 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.92706200 |
| 52 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.88618677 |
| 53 | tolerance induction (GO:0002507) | 2.85671474 |
| 54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85342358 |
| 55 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.83313827 |
| 56 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.82098118 |
| 57 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.81884973 |
| 58 | response to type I interferon (GO:0034340) | 2.81470160 |
| 59 | alanine transport (GO:0032328) | 2.81346242 |
| 60 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.81333453 |
| 61 | synaptic vesicle maturation (GO:0016188) | 2.80769162 |
| 62 | histone H4 deacetylation (GO:0070933) | 2.80755995 |
| 63 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.78863414 |
| 64 | detection of biotic stimulus (GO:0009595) | 2.78590960 |
| 65 | histone H3-K4 trimethylation (GO:0080182) | 2.78563831 |
| 66 | regulation of leukocyte degranulation (GO:0043300) | 2.77819336 |
| 67 | positive thymic T cell selection (GO:0045059) | 2.77589496 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 2.77387293 |
| 69 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.76747106 |
| 70 | negative regulation of innate immune response (GO:0045824) | 2.76551608 |
| 71 | negative regulation of sterol transport (GO:0032372) | 2.76301856 |
| 72 | negative regulation of cholesterol transport (GO:0032375) | 2.76301856 |
| 73 | type I interferon signaling pathway (GO:0060337) | 2.76241898 |
| 74 | cellular response to type I interferon (GO:0071357) | 2.76241898 |
| 75 | negative regulation of T cell mediated immunity (GO:0002710) | 2.75536810 |
| 76 | immunoglobulin mediated immune response (GO:0016064) | 2.75429075 |
| 77 | positive regulation of protein deacetylation (GO:0090312) | 2.75108865 |
| 78 | kynurenine metabolic process (GO:0070189) | 2.74690274 |
| 79 | positive T cell selection (GO:0043368) | 2.72613534 |
| 80 | response to laminar fluid shear stress (GO:0034616) | 2.71740956 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 2.71443342 |
| 82 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.70058807 |
| 83 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.69665738 |
| 84 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.67762081 |
| 85 | signal complex assembly (GO:0007172) | 2.67681974 |
| 86 | negative regulation of interleukin-12 production (GO:0032695) | 2.66771076 |
| 87 | regulation of B cell differentiation (GO:0045577) | 2.63217059 |
| 88 | mannose metabolic process (GO:0006013) | 2.62922987 |
| 89 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.62353427 |
| 90 | T cell selection (GO:0045058) | 2.62166850 |
| 91 | phospholipid scrambling (GO:0017121) | 2.61324080 |
| 92 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.60766662 |
| 93 | regulation of Rap GTPase activity (GO:0032317) | 2.60747446 |
| 94 | thymic T cell selection (GO:0045061) | 2.60318803 |
| 95 | aromatic amino acid family catabolic process (GO:0009074) | 2.60049938 |
| 96 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.59555448 |
| 97 | activation of JUN kinase activity (GO:0007257) | 2.58345827 |
| 98 | glutamate metabolic process (GO:0006536) | 2.58215010 |
| 99 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.57810695 |
| 100 | positive regulation of B cell differentiation (GO:0045579) | 2.57729977 |
| 101 | pre-miRNA processing (GO:0031054) | 2.57370798 |
| 102 | negative regulation of type 2 immune response (GO:0002829) | 2.56760324 |
| 103 | detection of molecule of bacterial origin (GO:0032490) | 2.56370898 |
| 104 | NIK/NF-kappaB signaling (GO:0038061) | 2.55339551 |
| 105 | regulation of tolerance induction (GO:0002643) | 2.54956551 |
| 106 | lysine metabolic process (GO:0006553) | 2.54599256 |
| 107 | lysine catabolic process (GO:0006554) | 2.54599256 |
| 108 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.54216471 |
| 109 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.53842256 |
| 110 | peptidyl-lysine dimethylation (GO:0018027) | 2.53664782 |
| 111 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.53437376 |
| 112 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.53234176 |
| 113 | Peyers patch development (GO:0048541) | 2.53234176 |
| 114 | histone H3-K9 demethylation (GO:0033169) | 2.52767970 |
| 115 | negative regulation of granulocyte differentiation (GO:0030853) | 2.52583178 |
| 116 | activated T cell proliferation (GO:0050798) | 2.51901895 |
| 117 | urea cycle (GO:0000050) | 2.51801194 |
| 118 | urea metabolic process (GO:0019627) | 2.51801194 |
| 119 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.50480382 |
| 120 | stress granule assembly (GO:0034063) | 2.50472131 |
| 121 | defense response to protozoan (GO:0042832) | 2.49996720 |
| 122 | complement activation, alternative pathway (GO:0006957) | 2.49130149 |
| 123 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.49011479 |
| 124 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.48570730 |
| 125 | histone H3-K9 modification (GO:0061647) | 2.48041722 |
| 126 | negative regulation of cell size (GO:0045792) | 2.48023595 |
| 127 | 2-oxoglutarate metabolic process (GO:0006103) | 2.47729906 |
| 128 | natural killer cell differentiation (GO:0001779) | 2.47682850 |
| 129 | high-density lipoprotein particle remodeling (GO:0034375) | 2.47482247 |
| 130 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.47013662 |
| 131 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.46843337 |
| 132 | histone H3-K4 methylation (GO:0051568) | 2.46440646 |
| 133 | histone lysine demethylation (GO:0070076) | 2.46054437 |
| 134 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.45863923 |
| 135 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.45541424 |
| 136 | neutrophil activation (GO:0042119) | 2.45541255 |
| 137 | histone H3 deacetylation (GO:0070932) | 2.45300308 |
| 138 | phospholipid homeostasis (GO:0055091) | 2.45264588 |
| 139 | cellular modified amino acid catabolic process (GO:0042219) | 2.45042673 |
| 140 | potassium ion import (GO:0010107) | 2.42853433 |
| 141 | bile acid biosynthetic process (GO:0006699) | 2.42524918 |
| 142 | positive regulation of glycogen metabolic process (GO:0070875) | 2.41581085 |
| 143 | regulation of protein activation cascade (GO:2000257) | 2.41471030 |
| 144 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.40238306 |
| 145 | layer formation in cerebral cortex (GO:0021819) | 2.38959958 |
| 146 | prepulse inhibition (GO:0060134) | 2.38407947 |
| 147 | negative regulation of fibrinolysis (GO:0051918) | 2.36225478 |
| 148 | ethanol oxidation (GO:0006069) | 2.33420339 |
| 149 | cellular potassium ion homeostasis (GO:0030007) | 2.32629162 |
| 150 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.31430951 |
| 151 | sulfur amino acid catabolic process (GO:0000098) | 2.30616196 |
| 152 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.29344319 |
| 153 | cell communication by electrical coupling (GO:0010644) | 2.29032672 |
| 154 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.28527335 |
| 155 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.28478358 |
| 156 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.26861162 |
| 157 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.26543278 |
| 158 | regulation of complement activation (GO:0030449) | 2.26178165 |
| 159 | negative regulation of heart growth (GO:0061117) | 2.26049112 |
| 160 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.26049112 |
| 161 | phospholipid efflux (GO:0033700) | 2.25288265 |
| 162 | activation of protein kinase A activity (GO:0034199) | 2.25050759 |
| 163 | fatty acid homeostasis (GO:0055089) | 2.23532080 |
| 164 | glyoxylate metabolic process (GO:0046487) | 2.23150352 |
| 165 | regulation of fibrinolysis (GO:0051917) | 2.22949535 |
| 166 | negative regulation of lipid transport (GO:0032369) | 2.22323698 |
| 167 | indole-containing compound catabolic process (GO:0042436) | 2.22284156 |
| 168 | indolalkylamine catabolic process (GO:0046218) | 2.22284156 |
| 169 | tryptophan catabolic process (GO:0006569) | 2.22284156 |
| 170 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.22231604 |
| 171 | protein carboxylation (GO:0018214) | 2.22231604 |
| 172 | nitrogen cycle metabolic process (GO:0071941) | 2.22041183 |
| 173 | reverse cholesterol transport (GO:0043691) | 2.22026242 |
| 174 | negative T cell selection (GO:0043383) | 2.20924877 |
| 175 | endothelial cell chemotaxis (GO:0035767) | 2.20062203 |
| 176 | positive regulation of lipid catabolic process (GO:0050996) | 2.19539570 |
| 177 | cellular sodium ion homeostasis (GO:0006883) | 2.18251726 |
| 178 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.17477960 |
| 179 | cell-substrate adherens junction assembly (GO:0007045) | 2.15853346 |
| 180 | focal adhesion assembly (GO:0048041) | 2.15853346 |
| 181 | valine metabolic process (GO:0006573) | 2.15738311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.63325310 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 2.96060155 |
| 3 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.88062587 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.86409481 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.74773453 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.73025229 |
| 7 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.63321088 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.57940801 |
| 9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.42356459 |
| 10 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.31723091 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.30811533 |
| 12 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.29944685 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.29862470 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23027863 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.20752331 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.20401587 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.19919070 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19365533 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.16918258 |
| 20 | KDM2B_26808549_Chip-Seq_K562_Human | 2.16148396 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.13245391 |
| 22 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.02692756 |
| 23 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 2.01247743 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.95279369 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.93320779 |
| 26 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.88129138 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88040899 |
| 28 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.88038720 |
| 29 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86851975 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.86157461 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.86092800 |
| 32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.85504471 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83470971 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82310435 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81829634 |
| 36 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.81134834 |
| 37 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.70936749 |
| 38 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70377352 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68836783 |
| 40 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.62461158 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.60750513 |
| 42 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.57734988 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57512258 |
| 44 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.57031358 |
| 45 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54918807 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53461772 |
| 47 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.52684876 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52240635 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51353065 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51183564 |
| 51 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.51146861 |
| 52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47279893 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46704713 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43177915 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.41903054 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41366765 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40748869 |
| 58 | * P68_20966046_ChIP-Seq_HELA_Human | 1.39203812 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.38905617 |
| 60 | MAF_26560356_Chip-Seq_TH1_Human | 1.37873721 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36430480 |
| 62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.33377008 |
| 63 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.31901405 |
| 64 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.31578982 |
| 65 | MYB_26560356_Chip-Seq_TH2_Human | 1.30295188 |
| 66 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29590800 |
| 67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.27409316 |
| 68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27091592 |
| 69 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.26566211 |
| 70 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.26518465 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25545878 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24580881 |
| 73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24008426 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23749267 |
| 75 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.23479988 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22370125 |
| 77 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22040827 |
| 78 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21788316 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20910722 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20502748 |
| 81 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20139350 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20108959 |
| 83 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20011584 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18553225 |
| 85 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.18350752 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.18259606 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15944140 |
| 88 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15749140 |
| 89 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.14871458 |
| 90 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12372108 |
| 91 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11797251 |
| 92 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11643350 |
| 93 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.11393633 |
| 94 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10406520 |
| 95 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10360662 |
| 96 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07412386 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07393880 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06415967 |
| 99 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05956673 |
| 100 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05898621 |
| 101 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.05624698 |
| 102 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05418462 |
| 103 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05418462 |
| 104 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04083277 |
| 105 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.03938583 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03064516 |
| 107 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02757030 |
| 108 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01414859 |
| 109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01403088 |
| 110 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00716543 |
| 111 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00301499 |
| 112 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00146723 |
| 113 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99931270 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99868838 |
| 115 | MAF_26560356_Chip-Seq_TH2_Human | 0.99070438 |
| 116 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.98943737 |
| 117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97964668 |
| 118 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97767178 |
| 119 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97479415 |
| 120 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96911232 |
| 121 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96817048 |
| 122 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.96692088 |
| 123 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.96692088 |
| 124 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96455064 |
| 125 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95625292 |
| 126 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.95304625 |
| 127 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94907841 |
| 128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94746767 |
| 129 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.92833552 |
| 130 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92349762 |
| 131 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92153527 |
| 132 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92115740 |
| 133 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91864300 |
| 134 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.90128373 |
| 135 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88741595 |
| 136 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.87981517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.06697314 |
| 2 | MP0003436_decreased_susceptibility_to | 4.00780968 |
| 3 | MP0005365_abnormal_bile_salt | 3.82484093 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.59588364 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.43498457 |
| 6 | MP0003724_increased_susceptibility_to | 3.36722793 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.12023691 |
| 8 | MP0008961_abnormal_basal_metabolism | 3.10096570 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.98916911 |
| 10 | MP0003252_abnormal_bile_duct | 2.90384030 |
| 11 | MP0002822_catalepsy | 2.72442130 |
| 12 | MP0001800_abnormal_humoral_immune | 2.55026264 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.51443302 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.47897197 |
| 15 | MP0001790_abnormal_immune_system | 2.45907780 |
| 16 | MP0005387_immune_system_phenotype | 2.45907780 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.42267445 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 2.40905283 |
| 19 | MP0002419_abnormal_innate_immunity | 2.37068867 |
| 20 | MP0005025_abnormal_response_to | 2.32985280 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.28873872 |
| 22 | MP0008260_abnormal_autophagy | 2.16179441 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.15435998 |
| 24 | MP0002723_abnormal_immune_serum | 2.15296435 |
| 25 | MP0009278_abnormal_bone_marrow | 2.14367371 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.11205023 |
| 27 | MP0001819_abnormal_immune_cell | 2.09331733 |
| 28 | MP0003300_gastrointestinal_ulcer | 2.04642966 |
| 29 | MP0005671_abnormal_response_to | 2.01872213 |
| 30 | MP0002452_abnormal_antigen_presenting | 2.00045770 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.99210087 |
| 32 | MP0009840_abnormal_foam_cell | 1.96930204 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.92501630 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.92326409 |
| 35 | MP0004130_abnormal_muscle_cell | 1.89176885 |
| 36 | MP0005083_abnormal_biliary_tract | 1.86272839 |
| 37 | MP0004381_abnormal_hair_follicle | 1.86073504 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.83826214 |
| 39 | MP0002405_respiratory_system_inflammati | 1.82109855 |
| 40 | MP0002398_abnormal_bone_marrow | 1.81289939 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.77019265 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.75549909 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.73655304 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.73414199 |
| 45 | MP0000716_abnormal_immune_system | 1.70702021 |
| 46 | MP0001666_abnormal_nutrient_absorption | 1.66717326 |
| 47 | MP0001849_ear_inflammation | 1.66555241 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.65854270 |
| 49 | MP0009785_altered_susceptibility_to | 1.64277410 |
| 50 | MP0002933_joint_inflammation | 1.59752482 |
| 51 | MP0000609_abnormal_liver_physiology | 1.54037099 |
| 52 | MP0006082_CNS_inflammation | 1.51245113 |
| 53 | MP0003635_abnormal_synaptic_transmissio | 1.50454241 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.45744865 |
| 55 | MP0002722_abnormal_immune_system | 1.45335211 |
| 56 | MP0005451_abnormal_body_composition | 1.44631827 |
| 57 | MP0005670_abnormal_white_adipose | 1.44251660 |
| 58 | MP0003866_abnormal_defecation | 1.43753701 |
| 59 | MP0003303_peritoneal_inflammation | 1.42536880 |
| 60 | MP0005409_darkened_coat_color | 1.38302260 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.37344836 |
| 62 | MP0004885_abnormal_endolymph | 1.36225715 |
| 63 | MP0002429_abnormal_blood_cell | 1.36034637 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.35933642 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.35884272 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.35137320 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.35137320 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.34941200 |
| 69 | MP0008569_lethality_at_weaning | 1.33575112 |
| 70 | MP0003828_pulmonary_edema | 1.33309717 |
| 71 | MP0008874_decreased_physiological_sensi | 1.30274501 |
| 72 | MP0001851_eye_inflammation | 1.29667283 |
| 73 | MP0002132_abnormal_respiratory_system | 1.29226599 |
| 74 | MP0003283_abnormal_digestive_organ | 1.28594820 |
| 75 | MP0000003_abnormal_adipose_tissue | 1.28454694 |
| 76 | MP0005375_adipose_tissue_phenotype | 1.28167714 |
| 77 | MP0001845_abnormal_inflammatory_respons | 1.26356779 |
| 78 | MP0000858_altered_metastatic_potential | 1.25053245 |
| 79 | MP0005666_abnormal_adipose_tissue | 1.22957595 |
| 80 | MP0003279_aneurysm | 1.22302149 |
| 81 | MP0003183_abnormal_peptide_metabolism | 1.19866776 |
| 82 | MP0004185_abnormal_adipocyte_glucose | 1.19403730 |
| 83 | MP0003075_altered_response_to | 1.18725932 |
| 84 | MP0004858_abnormal_nervous_system | 1.18576138 |
| 85 | MP0002148_abnormal_hypersensitivity_rea | 1.18331193 |
| 86 | MP0003091_abnormal_cell_migration | 1.14309176 |
| 87 | MP0002928_abnormal_bile_duct | 1.14232750 |
| 88 | MP0002166_altered_tumor_susceptibility | 1.13536915 |
| 89 | MP0003329_amyloid_beta_deposits | 1.12443564 |
| 90 | MP0000678_abnormal_parathyroid_gland | 1.11689466 |
| 91 | MP0003787_abnormal_imprinting | 1.11205983 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 1.09650764 |
| 93 | MP0001958_emphysema | 1.08653399 |
| 94 | MP0004510_myositis | 1.08163156 |
| 95 | MP0003045_fibrosis | 1.07413179 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 1.05825633 |
| 97 | MP0002254_reproductive_system_inflammat | 1.05110161 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 1.04955636 |
| 99 | MP0005310_abnormal_salivary_gland | 1.04559421 |
| 100 | MP0002249_abnormal_larynx_morphology | 1.04358548 |
| 101 | MP0000685_abnormal_immune_system | 1.03637052 |
| 102 | MP0002009_preneoplasia | 1.02820583 |
| 103 | MP0003172_abnormal_lysosome_physiology | 1.01964374 |
| 104 | MP0008469_abnormal_protein_level | 1.01459756 |
| 105 | MP0003763_abnormal_thymus_physiology | 1.01160882 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 1.00195031 |
| 107 | MP0001348_abnormal_lacrimal_gland | 0.98813948 |
| 108 | MP0002971_abnormal_brown_adipose | 0.98018300 |
| 109 | MP0010630_abnormal_cardiac_muscle | 0.97870553 |
| 110 | MP0002063_abnormal_learning/memory/cond | 0.97274227 |
| 111 | MP0000751_myopathy | 0.95881247 |
| 112 | MP0003868_abnormal_feces_composition | 0.95531635 |
| 113 | MP0005332_abnormal_amino_acid | 0.95318144 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93123522 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.93009549 |
| 116 | MP0002089_abnormal_postnatal_growth/wei | 0.91934131 |
| 117 | MP0002138_abnormal_hepatobiliary_system | 0.91309693 |
| 118 | MP0005499_abnormal_olfactory_system | 0.90755591 |
| 119 | MP0005394_taste/olfaction_phenotype | 0.90755591 |
| 120 | MP0005390_skeleton_phenotype | 0.89769996 |
| 121 | MP0009672_abnormal_birth_weight | 0.86340414 |
| 122 | MP0000767_abnormal_smooth_muscle | 0.86267962 |
| 123 | MP0001663_abnormal_digestive_system | 0.86235788 |
| 124 | MP0003878_abnormal_ear_physiology | 0.85167597 |
| 125 | MP0005377_hearing/vestibular/ear_phenot | 0.85167597 |
| 126 | MP0001984_abnormal_olfaction | 0.82722167 |
| 127 | MP0002064_seizures | 0.82465198 |
| 128 | MP0008770_decreased_survivor_rate | 0.81642325 |
| 129 | MP0010368_abnormal_lymphatic_system | 0.81408792 |
| 130 | MP0004087_abnormal_muscle_fiber | 0.81331730 |
| 131 | MP0009745_abnormal_behavioral_response | 0.79457177 |
| 132 | MP0000703_abnormal_thymus_morphology | 0.78603644 |
| 133 | MP0004883_abnormal_blood_vessel | 0.76883135 |
| 134 | MP0005334_abnormal_fat_pad | 0.76593307 |
| 135 | MP0005187_abnormal_penis_morphology | 0.76439054 |
| 136 | MP0000249_abnormal_blood_vessel | 0.76311936 |
| 137 | MP0009115_abnormal_fat_cell | 0.75129418 |
| 138 | MP0003633_abnormal_nervous_system | 0.74298579 |
| 139 | MP0004264_abnormal_extraembryonic_tissu | 0.73650628 |
| 140 | MP0000604_amyloidosis | 0.73516468 |
| 141 | MP0005319_abnormal_enzyme/_coenzyme | 0.71794365 |
| 142 | MP0005535_abnormal_body_temperature | 0.71792960 |
| 143 | MP0002069_abnormal_eating/drinking_beha | 0.71641573 |
| 144 | MP0003879_abnormal_hair_cell | 0.70236450 |
| 145 | MP0001986_abnormal_taste_sensitivity | 0.70175938 |
| 146 | MP0003690_abnormal_glial_cell | 0.69550902 |
| 147 | MP0001486_abnormal_startle_reflex | 0.69114135 |
| 148 | MP0009764_decreased_sensitivity_to | 0.68443025 |
| 149 | MP0003566_abnormal_cell_adhesion | 0.68413106 |
| 150 | MP0002269_muscular_atrophy | 0.67941177 |
| 151 | MP0002970_abnormal_white_adipose | 0.67077217 |
| 152 | MP0005166_decreased_susceptibility_to | 0.66618576 |
| 153 | MP0003795_abnormal_bone_structure | 0.66479171 |
| 154 | MP0004947_skin_inflammation | 0.66328446 |
| 155 | MP0006138_congestive_heart_failure | 0.65804055 |
| 156 | MP0009931_abnormal_skin_appearance | 0.65446808 |
| 157 | MP0005220_abnormal_exocrine_pancreas | 0.64871573 |
| 158 | MP0000598_abnormal_liver_morphology | 0.64536343 |
| 159 | MP0004811_abnormal_neuron_physiology | 0.64256306 |
| 160 | MP0005423_abnormal_somatic_nervous | 0.63681011 |
| 161 | MP0000733_abnormal_muscle_development | 0.63456224 |
| 162 | MP0009643_abnormal_urine_homeostasis | 0.62004492 |
| 163 | MP0000747_muscle_weakness | 0.61913465 |
| 164 | MP0005551_abnormal_eye_electrophysiolog | 0.60876847 |
| 165 | MP0001873_stomach_inflammation | 0.60358984 |
| 166 | MP0005448_abnormal_energy_balance | 0.59914398 |
| 167 | MP0002572_abnormal_emotion/affect_behav | 0.59004331 |
| 168 | MP0002925_abnormal_cardiovascular_devel | 0.57924628 |
| 169 | MP0001765_abnormal_ion_homeostasis | 0.56883345 |
| 170 | MP0004085_abnormal_heartbeat | 0.55859924 |
| 171 | MP0000266_abnormal_heart_morphology | 0.55744596 |
| 172 | MP0001502_abnormal_circadian_rhythm | 0.55738584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.11063834 |
| 2 | Obstructive sleep apnea (HP:0002870) | 3.94635223 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.87171954 |
| 4 | Hyperacusis (HP:0010780) | 3.65421372 |
| 5 | Increased IgE level (HP:0003212) | 3.59402388 |
| 6 | Myositis (HP:0100614) | 3.59239272 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.46980171 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.45887294 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 3.25803900 |
| 10 | Abnormality of the fingertips (HP:0001211) | 3.23044876 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.22401594 |
| 12 | Macroorchidism (HP:0000053) | 3.15810512 |
| 13 | Broad face (HP:0000283) | 3.05865917 |
| 14 | Abnormality of the lower motor neuron (HP:0002366) | 3.03446885 |
| 15 | Orchitis (HP:0100796) | 2.98209236 |
| 16 | Recurrent fungal infections (HP:0002841) | 2.93517047 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.89908795 |
| 18 | Gingivitis (HP:0000230) | 2.88886929 |
| 19 | Elfin facies (HP:0004428) | 2.87094442 |
| 20 | Cellulitis (HP:0100658) | 2.86428812 |
| 21 | Cerebral aneurysm (HP:0004944) | 2.86200702 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.81835261 |
| 23 | Pustule (HP:0200039) | 2.81373988 |
| 24 | Meningitis (HP:0001287) | 2.78126250 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.77715921 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74464304 |
| 27 | Obstructive lung disease (HP:0006536) | 2.74464304 |
| 28 | Insomnia (HP:0100785) | 2.73677828 |
| 29 | Prolonged bleeding time (HP:0003010) | 2.72635693 |
| 30 | Metaphyseal cupping (HP:0003021) | 2.71906103 |
| 31 | Hyperlipoproteinemia (HP:0010980) | 2.70802382 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 2.68901567 |
| 33 | Renovascular hypertension (HP:0100817) | 2.67088208 |
| 34 | Broad metatarsal (HP:0001783) | 2.66828981 |
| 35 | Hemiplegia (HP:0002301) | 2.66049966 |
| 36 | Pseudobulbar signs (HP:0002200) | 2.59186294 |
| 37 | Xanthomatosis (HP:0000991) | 2.59018966 |
| 38 | Retrobulbar optic neuritis (HP:0100654) | 2.57995290 |
| 39 | Optic neuritis (HP:0100653) | 2.57995290 |
| 40 | Papilledema (HP:0001085) | 2.55916678 |
| 41 | Complement deficiency (HP:0004431) | 2.47812939 |
| 42 | Vertebral arch anomaly (HP:0008438) | 2.43199136 |
| 43 | Chest pain (HP:0100749) | 2.41950565 |
| 44 | Emphysema (HP:0002097) | 2.40000437 |
| 45 | Vasculitis (HP:0002633) | 2.38753314 |
| 46 | Turricephaly (HP:0000262) | 2.38383419 |
| 47 | Thin bony cortex (HP:0002753) | 2.36892146 |
| 48 | Recurrent skin infections (HP:0001581) | 2.34775176 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.34184766 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.34184766 |
| 51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.28669112 |
| 52 | Ketosis (HP:0001946) | 2.28579156 |
| 53 | Back pain (HP:0003418) | 2.27663043 |
| 54 | Hemorrhage of the eye (HP:0011885) | 2.26274533 |
| 55 | Easy fatigability (HP:0003388) | 2.23901144 |
| 56 | Cervical subluxation (HP:0003308) | 2.23515466 |
| 57 | Intrahepatic cholestasis (HP:0001406) | 2.22864489 |
| 58 | Colitis (HP:0002583) | 2.22067266 |
| 59 | Dysostosis multiplex (HP:0000943) | 2.21973729 |
| 60 | Gastrointestinal stroma tumor (HP:0100723) | 2.21772878 |
| 61 | Neoplasm of the heart (HP:0100544) | 2.20441731 |
| 62 | Verrucae (HP:0200043) | 2.20121344 |
| 63 | Papilloma (HP:0012740) | 2.20121344 |
| 64 | Hypochromic anemia (HP:0001931) | 2.19952970 |
| 65 | Aneurysm (HP:0002617) | 2.18465212 |
| 66 | Hemoptysis (HP:0002105) | 2.18248210 |
| 67 | Supranuclear gaze palsy (HP:0000605) | 2.17040376 |
| 68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15973290 |
| 69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15973290 |
| 70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15973290 |
| 71 | Stomatitis (HP:0010280) | 2.15768631 |
| 72 | Epistaxis (HP:0000421) | 2.13263988 |
| 73 | Abnormality of the thoracic spine (HP:0100711) | 2.12695116 |
| 74 | Mucopolysacchariduria (HP:0008155) | 2.12352661 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12352661 |
| 76 | Recurrent viral infections (HP:0004429) | 2.12061214 |
| 77 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.11864910 |
| 78 | Dysmetric saccades (HP:0000641) | 2.10365174 |
| 79 | Agammaglobulinemia (HP:0004432) | 2.10133900 |
| 80 | J-shaped sella turcica (HP:0002680) | 2.09168859 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.08627365 |
| 82 | Heterotopia (HP:0002282) | 2.06301971 |
| 83 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06275567 |
| 84 | Malnutrition (HP:0004395) | 2.05625109 |
| 85 | Encephalitis (HP:0002383) | 2.05446088 |
| 86 | Lymphangioma (HP:0100764) | 2.04884033 |
| 87 | Enlarged penis (HP:0000040) | 2.04852310 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.01763714 |
| 89 | Restrictive lung disease (HP:0002091) | 1.99923870 |
| 90 | Onion bulb formation (HP:0003383) | 1.99181513 |
| 91 | Abnormal social behavior (HP:0012433) | 1.98729162 |
| 92 | Impaired social interactions (HP:0000735) | 1.98729162 |
| 93 | Hypercholesterolemia (HP:0003124) | 1.98514647 |
| 94 | Pointed chin (HP:0000307) | 1.97729155 |
| 95 | Polygenic inheritance (HP:0010982) | 1.95965217 |
| 96 | Obsessive-compulsive behavior (HP:0000722) | 1.95787235 |
| 97 | Postural instability (HP:0002172) | 1.95457930 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93595760 |
| 99 | Overriding aorta (HP:0002623) | 1.92510715 |
| 100 | Thoracic kyphosis (HP:0002942) | 1.92071491 |
| 101 | Pulmonary infiltrates (HP:0002113) | 1.90749420 |
| 102 | Panhypogammaglobulinemia (HP:0003139) | 1.89326970 |
| 103 | Annular pancreas (HP:0001734) | 1.89007804 |
| 104 | Hypertriglyceridemia (HP:0002155) | 1.88694414 |
| 105 | Granulocytopenia (HP:0001913) | 1.88236523 |
| 106 | T lymphocytopenia (HP:0005403) | 1.88096152 |
| 107 | Status epilepticus (HP:0002133) | 1.87179688 |
| 108 | Polycythemia (HP:0001901) | 1.87095992 |
| 109 | Distal upper limb amyotrophy (HP:0007149) | 1.86489565 |
| 110 | Upper limb amyotrophy (HP:0009129) | 1.86489565 |
| 111 | Visual hallucinations (HP:0002367) | 1.86456366 |
| 112 | Gastrointestinal inflammation (HP:0004386) | 1.85372545 |
| 113 | Osteomyelitis (HP:0002754) | 1.85327426 |
| 114 | Slow saccadic eye movements (HP:0000514) | 1.85092274 |
| 115 | Seborrheic dermatitis (HP:0001051) | 1.84825490 |
| 116 | Renal duplication (HP:0000075) | 1.84703680 |
| 117 | Long toe (HP:0010511) | 1.84195127 |
| 118 | Disproportionate tall stature (HP:0001519) | 1.83843485 |
| 119 | Mitral stenosis (HP:0001718) | 1.83390764 |
| 120 | Stridor (HP:0010307) | 1.82783217 |
| 121 | Pulmonary embolism (HP:0002204) | 1.81266113 |
| 122 | Spastic diplegia (HP:0001264) | 1.80049939 |
| 123 | Ulnar bowing (HP:0003031) | 1.79548107 |
| 124 | Keratoconjunctivitis (HP:0001096) | 1.78741626 |
| 125 | Hypochromic microcytic anemia (HP:0004840) | 1.78480577 |
| 126 | Lymphopenia (HP:0001888) | 1.78220035 |
| 127 | Ketoacidosis (HP:0001993) | 1.77702915 |
| 128 | Abnormality of the diencephalon (HP:0010662) | 1.77389350 |
| 129 | Shallow orbits (HP:0000586) | 1.75388569 |
| 130 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.75302137 |
| 131 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.75189461 |
| 132 | Increased cerebral lipofuscin (HP:0011813) | 1.74757509 |
| 133 | Mitral valve prolapse (HP:0001634) | 1.74373393 |
| 134 | Neonatal onset (HP:0003623) | 1.74307888 |
| 135 | Abnormality of the columella (HP:0009929) | 1.74295856 |
| 136 | Difficulty running (HP:0009046) | 1.73621619 |
| 137 | Systemic lupus erythematosus (HP:0002725) | 1.72160100 |
| 138 | Premature loss of primary teeth (HP:0006323) | 1.71988634 |
| 139 | Distal lower limb amyotrophy (HP:0008944) | 1.71415198 |
| 140 | Arnold-Chiari malformation (HP:0002308) | 1.71236990 |
| 141 | Abnormality of complement system (HP:0005339) | 1.71223282 |
| 142 | Visceral angiomatosis (HP:0100761) | 1.71019732 |
| 143 | Peritonitis (HP:0002586) | 1.70956626 |
| 144 | Ventricular fibrillation (HP:0001663) | 1.70657488 |
| 145 | Abnormality of T cell number (HP:0011839) | 1.70010983 |
| 146 | Abnormality of the common coagulation pathway (HP:0010990) | 1.69892153 |
| 147 | Biconcave vertebral bodies (HP:0004586) | 1.68696044 |
| 148 | Urticaria (HP:0001025) | 1.68439466 |
| 149 | Spontaneous hematomas (HP:0007420) | 1.68366594 |
| 150 | Hemangiomatosis (HP:0007461) | 1.68279359 |
| 151 | Dislocated radial head (HP:0003083) | 1.68028682 |
| 152 | Esophageal varix (HP:0002040) | 1.67747890 |
| 153 | Myocardial infarction (HP:0001658) | 1.67492254 |
| 154 | Genetic anticipation (HP:0003743) | 1.67235508 |
| 155 | Abnormality of the peritoneum (HP:0002585) | 1.66726816 |
| 156 | Focal seizures (HP:0007359) | 1.66383412 |
| 157 | Gout (HP:0001997) | 1.65367057 |
| 158 | Inflammation of the large intestine (HP:0002037) | 1.64604656 |
| 159 | Stroke (HP:0001297) | 1.64253005 |
| 160 | Exercise-induced myalgia (HP:0003738) | 1.63606602 |
| 161 | Hyperglycinuria (HP:0003108) | 1.63550944 |
| 162 | Neuronal loss in central nervous system (HP:0002529) | 1.62841511 |
| 163 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.62667921 |
| 164 | Epidermoid cyst (HP:0200040) | 1.62459753 |
| 165 | Arterial thrombosis (HP:0004420) | 1.62286781 |
| 166 | Hypertensive crisis (HP:0100735) | 1.61920544 |
| 167 | Myokymia (HP:0002411) | 1.59779193 |
| 168 | EMG: neuropathic changes (HP:0003445) | 1.59155590 |
| 169 | Abnormality of the Achilles tendon (HP:0005109) | 1.58980873 |
| 170 | Flat cornea (HP:0007720) | 1.56257416 |
| 171 | Hematochezia (HP:0002573) | 1.56047212 |
| 172 | Precocious puberty (HP:0000826) | 1.55890737 |
| 173 | Aortic aneurysm (HP:0004942) | 1.55642064 |
| 174 | Hypoplasia of the thymus (HP:0000778) | 1.54207502 |
| 175 | Rapidly progressive (HP:0003678) | 1.53492359 |
| 176 | Reticulocytosis (HP:0001923) | 1.53440928 |
| 177 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.53220367 |
| 178 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.53220367 |
| 179 | Anal stenosis (HP:0002025) | 1.53177337 |
| 180 | Hand muscle atrophy (HP:0009130) | 1.52758165 |
| 181 | Narrow palate (HP:0000189) | 1.52651290 |
| 182 | Hyperammonemia (HP:0001987) | 1.52414926 |
| 183 | Depression (HP:0000716) | 1.51200685 |
| 184 | Cerebral inclusion bodies (HP:0100314) | 1.50804546 |
| 185 | Generalized hyperpigmentation (HP:0007440) | 1.50473087 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.56270605 |
| 2 | MAP3K10 | 3.38131613 |
| 3 | PRPF4B | 2.99875895 |
| 4 | PKN2 | 2.96201262 |
| 5 | SIK2 | 2.95602090 |
| 6 | ERN1 | 2.65430281 |
| 7 | EEF2K | 2.48627691 |
| 8 | SIK1 | 2.35874245 |
| 9 | ICK | 2.09664872 |
| 10 | CAMK1G | 2.09540259 |
| 11 | FGFR4 | 2.04834414 |
| 12 | MAP3K7 | 2.01601422 |
| 13 | MAP2K3 | 1.97045167 |
| 14 | MAP4K1 | 1.90655404 |
| 15 | CDK12 | 1.81636302 |
| 16 | PTK6 | 1.80783028 |
| 17 | MAP3K13 | 1.78175567 |
| 18 | BLK | 1.77457738 |
| 19 | TYRO3 | 1.74696272 |
| 20 | FGFR2 | 1.71196614 |
| 21 | CAMK1D | 1.60247831 |
| 22 | SMG1 | 1.59630945 |
| 23 | SIK3 | 1.59498479 |
| 24 | GRK6 | 1.57420931 |
| 25 | DAPK2 | 1.54226555 |
| 26 | RIPK1 | 1.48532285 |
| 27 | MAP3K9 | 1.46641159 |
| 28 | IRAK4 | 1.41365642 |
| 29 | JAK3 | 1.40751478 |
| 30 | EPHA4 | 1.37932463 |
| 31 | MARK2 | 1.36746393 |
| 32 | MAP3K6 | 1.35292427 |
| 33 | MAP3K14 | 1.32117739 |
| 34 | PDGFRA | 1.31207328 |
| 35 | PRKCH | 1.25192473 |
| 36 | MAP3K3 | 1.25145931 |
| 37 | TTN | 1.23384386 |
| 38 | TBK1 | 1.20851036 |
| 39 | STK38 | 1.17960133 |
| 40 | PRKD3 | 1.16638036 |
| 41 | BRD4 | 1.13796853 |
| 42 | IKBKE | 1.11783574 |
| 43 | TAOK1 | 1.09853138 |
| 44 | NTRK2 | 1.06020938 |
| 45 | MTOR | 1.04281773 |
| 46 | CDC42BPA | 1.01286227 |
| 47 | KSR2 | 1.01166216 |
| 48 | FGFR3 | 0.99493230 |
| 49 | PRKD2 | 0.98399253 |
| 50 | PAK6 | 0.97764959 |
| 51 | TNK2 | 0.97460694 |
| 52 | ALK | 0.96330024 |
| 53 | LRRK2 | 0.94335737 |
| 54 | RPS6KL1 | 0.92982787 |
| 55 | RPS6KC1 | 0.92982787 |
| 56 | MAP3K1 | 0.92879651 |
| 57 | SYK | 0.92832179 |
| 58 | SGK3 | 0.91326246 |
| 59 | MAP3K11 | 0.90682499 |
| 60 | CAMKK1 | 0.89601433 |
| 61 | FES | 0.89100219 |
| 62 | TXK | 0.88133108 |
| 63 | RET | 0.86351313 |
| 64 | DYRK1B | 0.85652743 |
| 65 | JAK1 | 0.84739604 |
| 66 | PDGFRB | 0.84018387 |
| 67 | EPHB1 | 0.82652113 |
| 68 | PRKD1 | 0.82624102 |
| 69 | PHKG1 | 0.81845884 |
| 70 | PHKG2 | 0.81845884 |
| 71 | CAMK4 | 0.81110566 |
| 72 | LCK | 0.79773354 |
| 73 | RPS6KA6 | 0.79092157 |
| 74 | BCKDK | 0.79091421 |
| 75 | ITK | 0.78285616 |
| 76 | JAK2 | 0.78266979 |
| 77 | LMTK2 | 0.77630099 |
| 78 | UHMK1 | 0.77365840 |
| 79 | HCK | 0.75901355 |
| 80 | HIPK2 | 0.75899959 |
| 81 | NTRK3 | 0.75708206 |
| 82 | MAPK12 | 0.75272880 |
| 83 | FGR | 0.74112831 |
| 84 | BMX | 0.74066425 |
| 85 | KIT | 0.73689538 |
| 86 | CSF1R | 0.73567054 |
| 87 | LYN | 0.73136725 |
| 88 | MAP2K2 | 0.72810480 |
| 89 | STK11 | 0.72612453 |
| 90 | TGFBR2 | 0.71680034 |
| 91 | DMPK | 0.68632578 |
| 92 | WNK1 | 0.68192738 |
| 93 | INSRR | 0.67548443 |
| 94 | NEK2 | 0.65672291 |
| 95 | MAP2K6 | 0.65477598 |
| 96 | MAPK11 | 0.65273893 |
| 97 | TYK2 | 0.65203849 |
| 98 | IKBKB | 0.64932702 |
| 99 | CDK6 | 0.63868804 |
| 100 | CAMK1 | 0.62418467 |
| 101 | CSK | 0.62318451 |
| 102 | TAOK3 | 0.61565950 |
| 103 | PTK2 | 0.60255617 |
| 104 | MAP2K4 | 0.56914044 |
| 105 | ERBB2 | 0.56408423 |
| 106 | PRKAA2 | 0.56231466 |
| 107 | PDK1 | 0.54793456 |
| 108 | FGFR1 | 0.52914148 |
| 109 | PDPK1 | 0.52799431 |
| 110 | MAPK7 | 0.52120787 |
| 111 | PAK3 | 0.49774307 |
| 112 | PRKAA1 | 0.46457121 |
| 113 | DDR2 | 0.46413678 |
| 114 | RPS6KA2 | 0.46241887 |
| 115 | CHUK | 0.46065307 |
| 116 | CDK4 | 0.44114979 |
| 117 | ZAP70 | 0.44085024 |
| 118 | MAP3K4 | 0.43822386 |
| 119 | FYN | 0.43787380 |
| 120 | CDK5 | 0.42498981 |
| 121 | BTK | 0.42411068 |
| 122 | IRAK3 | 0.41943295 |
| 123 | MAP3K2 | 0.41557665 |
| 124 | TEC | 0.40979363 |
| 125 | DAPK1 | 0.40668249 |
| 126 | TAOK2 | 0.40501140 |
| 127 | PRKCZ | 0.40261361 |
| 128 | RPS6KA1 | 0.40131240 |
| 129 | NLK | 0.39819670 |
| 130 | EPHA3 | 0.38244313 |
| 131 | MARK3 | 0.38060497 |
| 132 | MAPK8 | 0.37584829 |
| 133 | RIPK4 | 0.37343408 |
| 134 | RPS6KA3 | 0.37256638 |
| 135 | MAPK15 | 0.37243655 |
| 136 | MAPK3 | 0.35957476 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.41775216 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61667249 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.31791221 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.25656085 |
| 5 | Lysine degradation_Homo sapiens_hsa00310 | 2.22156185 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12630474 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.08607546 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95631836 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.74106620 |
| 10 | Bile secretion_Homo sapiens_hsa04976 | 1.68117526 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.64884744 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.56880990 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48928251 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.48822281 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.48553321 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.45427291 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42798395 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40505375 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.39724230 |
| 20 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.39016988 |
| 21 | ABC transporters_Homo sapiens_hsa02010 | 1.35546235 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.33348185 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32393058 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31685906 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29746113 |
| 26 | Insulin resistance_Homo sapiens_hsa04931 | 1.27927022 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.26688803 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.23302724 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.22301342 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21274481 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.20765322 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.17921968 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17663059 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.17029213 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.16533835 |
| 36 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.15943803 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.14805006 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.13437536 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11686001 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11381340 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10649801 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.10164877 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10090999 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09804076 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.07271875 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07195640 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06582504 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05860179 |
| 49 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.04951469 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04914259 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04196039 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.03632407 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03362477 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03201854 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.02030659 |
| 56 | Malaria_Homo sapiens_hsa05144 | 1.01942447 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.00882995 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00608726 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.00564916 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99918306 |
| 61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.99871672 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99733656 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99494733 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97906176 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97354427 |
| 66 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.95153963 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94932260 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94004605 |
| 69 | Circadian entrainment_Homo sapiens_hsa04713 | 0.93518483 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.93448109 |
| 71 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.93186127 |
| 72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92444085 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91926324 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.91570019 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.91555781 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91371694 |
| 77 | Salivary secretion_Homo sapiens_hsa04970 | 0.90369778 |
| 78 | Glioma_Homo sapiens_hsa05214 | 0.88935674 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88724014 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.88507052 |
| 81 | Long-term potentiation_Homo sapiens_hsa04720 | 0.88275364 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.87761263 |
| 83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.87198748 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86840629 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86495872 |
| 86 | Morphine addiction_Homo sapiens_hsa05032 | 0.85161597 |
| 87 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83654545 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82966095 |
| 89 | GABAergic synapse_Homo sapiens_hsa04727 | 0.81801863 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81334219 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79847133 |
| 92 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78070220 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78002645 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77702499 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76932372 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76705678 |
| 97 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.76324319 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76020463 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75692303 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.75462905 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.75182169 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74454347 |
| 103 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74171903 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74136281 |
| 105 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73404208 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73266944 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.72823853 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72780584 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72736733 |
| 110 | Asthma_Homo sapiens_hsa05310 | 0.72227118 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71932858 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71828492 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71432408 |
| 114 | Renin secretion_Homo sapiens_hsa04924 | 0.71392190 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.70768373 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70562442 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70430453 |
| 118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.69852580 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68566262 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68142635 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68119432 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67445585 |
| 123 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67301725 |
| 124 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66980402 |
| 125 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66347317 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65888939 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64324530 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.64314198 |
| 129 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62345777 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61502361 |
| 131 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61019358 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60911289 |
| 133 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60538082 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57777373 |
| 135 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57295042 |
| 136 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56875138 |
| 137 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56235542 |
| 138 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54208512 |
| 139 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53938492 |
| 140 | Bladder cancer_Homo sapiens_hsa05219 | 0.53201411 |
| 141 | Lysosome_Homo sapiens_hsa04142 | 0.53011130 |
| 142 | Phagosome_Homo sapiens_hsa04145 | 0.52758804 |
| 143 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.52179784 |
| 144 | Melanogenesis_Homo sapiens_hsa04916 | 0.51983363 |
| 145 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51957225 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.51791074 |
| 147 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51429511 |
| 148 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51094691 |
| 149 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50940877 |
| 150 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50937294 |
| 151 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50922713 |
| 152 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50370355 |
| 153 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48729628 |
| 154 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48698502 |
| 155 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48209231 |
| 156 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47771210 |
| 157 | Platelet activation_Homo sapiens_hsa04611 | 0.46799583 |
| 158 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46413127 |
| 159 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45043034 |

